首页> 外国专利> MONOCLONAL ANTIBODY OF NERVE GROWTH FACTOR AND ENCODING GENE AND USE THEREOF

MONOCLONAL ANTIBODY OF NERVE GROWTH FACTOR AND ENCODING GENE AND USE THEREOF

机译:神经生长因子和编码基因的单克隆抗体及其用途

摘要

Disclosed are a monoclonal antibody of a nerve growth factor and an encoding gene thereof and the use thereof. The monoclonal antibody of the nerve growth factor of the present invention comprises heavy and light chains, wherein the heavy chain comprises a heavy chain constant region and a heavy chain variable region; the light chain comprises a light chain constant region and a light chain variable region; the heavy chain variable region includes three complementary determining regions HCDR1, HCDR2 and HCDR3; and the light chain variable region includes three complementary determining regions LCDR1, LCDR2 and LCDR3. The monoclonal antibody of the nerve growth factor of the present invention can specifically bind to the nerve growth factor, can be used for detecting the presence and/or level of the nerve growth factor, for preparing a drug that inhibits nerve-growth-factor-dependent proliferation in TF-1 cells, and for preparing a drug for treating or preventing at least one of neuropathic pain, chronic pain and inflammatory pain, and has good application prospects and market value.
机译:本发明公开了一种神经生长因子的单克隆抗体及其编码基因及其用途。本发明的神经生长因子的单克隆抗体包含重链和轻链,其中重链包含重链恒定区和重链可变区;轻链包括轻链恒定区和轻链可变区。重链可变区包括三个互补决定区HCDR1,HCDR2和HCDR3。轻链可变区包括三个互补决定区LCDR1,LCDR2和LCDR3。本发明的神经生长因子的单克隆抗体可以与神经生长因子特异性结合,可以用于检测神经生长因子的存在和/或水平,用于制备抑制神经生长因子的药物。依赖于TF-1细胞的增殖,制备用于治疗或预防神经性疼痛,慢性疼痛和炎性疼痛中的至少一种的药物,具有良好的应用前景和市场价值。

著录项

  • 公开/公告号WO2019201133A1

    专利类型

  • 公开/公告日2019-10-24

    原文格式PDF

  • 申请/专利权人 AKESO BIOPHARMA INC.;

    申请/专利号WO2019CN82107

  • 申请日2019-04-10

  • 分类号C07K16/22;C12N15/13;A61K39/395;A61P25;A61P29;A61P19/02;G01N33/68;G01N33/577;

  • 国家 WO

  • 入库时间 2022-08-21 11:52:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号